AKT1 and colonic neoplasm: This study has shown for the first time that aberrant expression of TPX2 is significantly associated with unfavorable clinicopathologic variables of colon cancer and that overexpression of TPX2 leads to the activation of Akt, a mechanism by which TPX2 promotes proliferation and tumorigenesis.